Abstract
After treatment for breast cancer, many women experience cognitive problems, as determined by objective neuropsychological tests. However, the ecological validity of these tests has been questioned. This study explored the trajectory of perceived attentional function from before to 24 months after surgery in women with breast cancer and examined the effect of adjuvant treatment on this perceived attentional function. Women with breast cancer (N = 200) were assessed for perceived cognitive function by measuring attentional function using the attentional function index (AFI). Covariates included anxiety, depression, fatigue, and sleep disturbance. Perceived attentional function declined in 54% of women at 1 month after surgery. At 1 and 2 years after surgery, 41 and 30% of women, respectively, still perceived this decline. The mean AFI decreased to the lowest point 1 month after surgery, but improved gradually afterward, taking about 1 year to return to the pre-surgery level. Decreases in perceived attentional function were associated with increases in anxiety, depression, fatigue, and sleep disturbance. After controlling for baseline differences and covariates, mean AFI scores were not associated with adjuvant treatment. Perceived cognitive function deteriorated after surgery but improved over time. It was not associated with adjuvant cancer treatment.
Similar content being viewed by others
References
Correa DD, Ahles TA (2007) Cognitive adverse effects of chemotherapy in breast cancer patients. Curr Opin Support Palliat Care 1:57–62
Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S (2009) Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psychooncology 18(2):134–143
Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430
Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D (2005) The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study. The Breast 14:142–150
Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1742–1745
Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D’Andrea G, Moasser M, Dang C, Poznak CV, Hurria A, Holland J (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54:925–931
Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, Bishop H, Hodson N, Mitra S, Sadler G, Shah E, Stein R, Whitehead S, Winstanley J (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834
Quesnel C, Savard J, Ivers H (2009) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116:113–123
Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650
Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955–969
Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP (2004) Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101:404–411
Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van den Bent MJ (2002) Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 95:183–192
Poppelreuter M, Weis J, Kulz AK, Tucha O, Lange KW, Bartsch HH (2004) Cognitive dysfunction and subjective complaints of cancer patients. A cross-sectional study in a cancer rehabilitation centre. Eur J Cancer 40:43–49
Klepstad P, Hilton P, Moen J, Fougner B, Borchgrevink PC, Kaasa S (2002) Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. Palliat Med 16:513–519
Booth-Jones M, Jacobsen PB, Ransom S, Soety E (2005) Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplant 36:695–702
Shilling V, Jenkins V (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 11:6–15
Chaytor N, Schmitter-Edgecombe M (2003) The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills. Neuropsychol Rev 13:181–197
Hermelink K, Kuchenhoff H, Untch M, Bauerfeind I, Lux MP, Buhner M, Manitz J, Fensterer V, Munzel K (2010) Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 19:1321–1328
Vardy JL, Xu W, Booth M, Park A, Dodd A, Rourke S, Dhillon S, Clarke SJ, Wanger L, Tannock IF (2008) Relation between perceived cognitive function and neuropsychological performance in cancer survivors. J Support Oncol 6:294–295
Cimprich B, Visovatti M, Ronis D (2011) The Attentional Function Index: a self-report measure of cognitive function. Psychooncology 20:194–202
Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123:25–34
Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J (2008) Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psychooncology 17:1189–1195
Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS (2008) Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 108:18–30
Price CC, Garvan CW, Monk TG (2008) Type and severity of cognitive decline in older adults after noncardiac surgery. Anesthesiology 108:8–17
Smith EE, Jonides J (1999) Storage and executive processes in the frontal lobes. Science 283:1657–1661
Cimprich B (1992) Attentional fatigue following breast cancer surgery. Res Nurs Health 15:199–207
Chiu YH (2002) Getting lost behavior and directed attention impairments in Taiwanese patients with early Alzheimer’s disease. School of Nursing. University of Michigan, Ann Arbor
Chiu YC, Algase D, Liang J, Liu HC, Lin KN (2005) Conceptualization and measurement of getting lost behavior in persons with early dementia. Int J Geriatr Psychiatry 20:760–768
Spielberger CD, Gorsuch RL, Suchene R, Vagg PR, HJacobs GA (1983) Manual for the State-Trait Anxiety Inventory (Form Y). Consulting Psychologists Press, Palo Alto, CA
Novy DM, Nelson DV, Goodwin J, Rowzee RD (1993) Psychometric comparability of the State-Trait Anxiety Inventory for different ethnic subpopulations. Psychol Assess 5:343–349
Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437–443
Hu LC (1999) The caregiving burden, depression and quality of life of primary caregivers of metastatic cancer patients receiving home care. Chang Gung University, Tao-Yuan
Lee KA, Hicks G, Nino-Murcia G (1991) Validity and reliability of a scale to assess fatigue. Psychiatry Res 36:291–298
Winstead-Fry P (1998) Psychometric assessment of four fatigue scales with a sample of rural cancer patients. J Nurs Meas 6:111–122
Meek PM, Nail LM, Barsevick A, Schwartz AL, Stephen S, Whitmer K, Beck SL, Jones LS, Walker BL (2000) Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res 49:181–190
Miaskowski C, Lee KA (1999) Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manag 17:320–332
Lee SY, Lee KA (2007) Early postpartum sleep and fatigue for mothers after cesarean delivery compared with vaginal delivery: an exploratory study. J Perinat Neonatal Nurs 21:109–113
Lee SY, Lee KA, Rankin SH, Weiss SJ, Alkon A (2007) Sleep disturbance, fatigue, and stress among Chinese-American parents with ICU hospitalized infants. Issues Ment Health Nurs 28:593–605
Tang WR, Yu CY, Yeh SJ (2010) Fatigue and its related factors in patients with chronic heart failure. J Clin Nurs 19:69–78
Lee KA (1992) Self-reported sleep disturbances in employed women. Sleep 15:493–498
Lee SY, Lee KA, Dawn A, Decker M (2010) Circadian activity rhythms for mothers with an infant in ICU. Front Neurol 155:1–5
Lee SY (2007) Validating the General Sleep Disturbance Scale among Chinese American parents with hospitalized infants. J Transcult Nurs 18:111–117
Jacobson NS, Truax P (1991) Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59:12–19
Little RJA, Rubin DB (1987) Statistical analysis with missing data. Wiley, New York
Wu L (2010) Mixed effects models for complex data. CRC Press Taylor & Francis Group, Boca Raton, FL
Pullens MJ, De Vries J, Roukema JA (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology 19:1127–1138
Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA (2004) ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer 101:466–475
Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299
Cimprich B, Ronis DL (2001) Attention and symptom distress in women with and without breast cancer. Nurs Res 50:86–94
Lehto RH, Cimprich B (1999) Anxiety and directed attention in women awaiting breast cancer surgery. Oncol Nurs Forum 26:767–772
Shilling V, Jenkins V, Fallowfield L, Howell T (2003) The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol 86:405–412
Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629
Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 66:108–118
Acknowledgments
This study was supported by the National Science Council of Taiwan (Grant number 94-2314-B-182-025, 95-2314-B-182-005, and 96-2628-B-182-032 to MLC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, ML., Miaskowski, C., Liu, LN. et al. Changes in perceived attentional function in women following breast cancer surgery. Breast Cancer Res Treat 131, 599–606 (2012). https://doi.org/10.1007/s10549-011-1760-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1760-3